UTI (Universal Technical Institute, Inc.) Stock Analysis - AI Report

Universal Technical Institute, Inc. (UTI) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, UTI trades at $36.83 with a market cap of $2.15B and a P/E ratio of 47.19. UTI moved +3.13% today. Year to date, UTI is +35.13%; over the trailing twelve months it is +4.78%. Its 52-week range spans $15.14 to $41.53. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces UTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on UTI?

Rallies AI research for UTI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

UTI Key Metrics

Key financial metrics for UTI
MetricValue
Price$36.83
Market Cap$2.15B
P/E Ratio47.19
EPS$0.78
Dividend Yield0.02%
52-Week High$41.53
52-Week Low$15.14
Volume4
Avg Volume0
Revenue (TTM)$868.99M
Net Income$42.68M
Gross Margin0.00%

Latest UTI News

Recent UTI Insider Trades

  • SRERE LINDA J sold 15.00K (~$548.80K) on May 11, 2026.
  • Kevane Christopher E. sold 23.65K (~$888.12K) on Mar 27, 2026.
  • Brochick George W. sold 5.00K (~$182.94K) on Mar 17, 2026.

UTI Analyst Consensus

6 analysts cover UTI: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.00.

Common questions about UTI

What is the AI research view on UTI?
Rallies AI research for UTI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for UTI?
Rallies AI research for UTI combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is UTI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTI. It does not provide personalized investment advice.
UTI

UTI